Evidence map›Paper›PMID 35644251›Full record

ArticleDevelopmental biology2022

An enhancer located in a Pde6c intron drives transient expression in the cone photoreceptors of developing mouse and human retinas.

Vismaya S Bachu, Sangeetha Kandoi, Ko Uoon Park, Michael L Kaufman, Michael Schwanke, Deepak A Lamba, Joseph A Brzezinski

Open access · greenAbstract read
In one paragraph

Article in Developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Vismaya S BachuDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sangeetha KandoiDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, USA.
Ko Uoon ParkDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Michael L KaufmanDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Michael SchwankeDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Deepak A LambaDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, USA.
Joseph A BrzezinskiDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Electronic address: joseph.brzezinski@cuanschutz.edu.
University of Colorado Anschutz Medical Campus · USUniversity of California, San Francisco · USJohns Hopkins University · US

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAMBA, DEEPAK ASHOK · 1985 to 2024
$16.8M
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision ResearchU24EY029891 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI CARROLL, JOSEPH, DUNCAN, JACQUE LYNNE · 2018 to 2022
$6.6M
Mechanisms of cell fate specification and competence regulation in photoreceptorsR01EY024272 · NEI · UNIVERSITY OF COLORADO DENVER · PI Joseph A Brzezinski · 2014 to 2026
$5.3M
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA modelR01EY032197 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ULLIAN, ERIK M · 2021 to 2025
$2.5M
NEI NIH HHS P30 EY002162NEI NIH HHS R01 EY024272NEI NIH HHS R01 EY032197NEI NIH HHS U24 EY029891
6 · The paper itself

Abstract

How cone photoreceptors are formed during retinal development is only partially known. This is in part because we do not fully understand the gene regulatory network responsible for cone genesis. We reasoned that cis-regulatory elements (enhancers) active in nascent cones would be regulated by the same upstream network that controls cone formation. To dissect this network, we searched for enhancers active in developing cones. By electroporating enhancer-driven fluorescent reporter plasmids, we observed that a sequence within an intron of the cone-specific Pde6c gene acted as an enhancer in developing mouse cones. Similar fluorescent reporter plasmids were used to generate stable transgenic human induced pluripotent stem cells that were then grown into three-dimensional human retinal organoids. These organoids contained fluorescently labeled cones, demonstrating that the Pde6c enhancer was also active in human cones. We observed that enhancer activity was transient and labeled a minor population of developing rod photoreceptors in both mouse and human systems. This cone-enriched pattern argues that the Pde6c enhancer is activated in cells poised between rod and cone fates. Additionally, it suggests that the Pde6c enhancer is activated by the same regulatory network that selects or stabilizes cone fate choice. To further understand this regulatory network, we identified essential enhancer sequence regions through a series of mutagenesis experiments. This suggested that the Pde6c enhancer was regulated by transcription factor binding at five or more locations. Binding site predictions implicated transcription factor families known to control photoreceptor formation and families not previously associated with cone development. These results provide a framework for deciphering the gene regulatory network that controls cone genesis in both human and mouse systems. Our new transgenic human stem cell lines provide a tool for determining which cone developmental mechanisms are shared and distinct between mice and humans.

Indexed as

Induced Pluripotent Stem CellsRetinal Cone Photoreceptor CellsAnimalsAnimals, Genetically ModifiedCyclic Nucleotide Phosphodiesterases, Type 6Eye ProteinsHumansIntronsMiceRetinaTranscription FactorsCyclic Nucleotide Phosphodiesterases, Type 6Eye ProteinsPDE6C protein, humanPde6c protein, mouseTranscription FactorsCone photoreceptorDevelopmentEnhanceriPSCPde6cRetinaRetinal organoid

Identifiers

PMID35644251
PMCPMC10676565
OpenAlexW4281561892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.